Factors affecting the termination of cardiovascular actions of 10, 10-difluoro, 13-dehydroprostacyclin

Experiments were conducted to determine why 10,10-difluoro, 13-dehydroprostacyclin (DF₂-PGI₂) has a long vascular relexant activity but like PGI₂ hads a short duration of effect . DF₂-PGI₂ produced depressor responses in anesthetized dogs which were not affected by nephrectomy suggesting that the kidney was not responsible for the termination of action. DF₂-PGI₂ given intravenously or into the ascending oarta produced depressor responses of a similar magnitude but injection of the same doses into the hepatic portal circulation resulted in a large attenuation of responses. The data suggest hepatitic, but not pulmonary, metabolism of DF₂-PGI₂. Injection or infusion of PGI₂ and DF₂-PGI₂ into the hindlimb circulation caused vasodilation of a similar duration suggesting diffusion from tissue sites as another mechanims of termination of action.